Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 2, 2001 - Issue 6
Submit an article Journal homepage
444
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Innovative cancer drug targets: genomics, transcriptomics and clinomics

Paul A Clarke CRC Centre for Cancer Therapeutics, Institute for Cancer Research, Block E, 15 Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, UK. [email protected]
&
Paul Workman CRC Centre for Cancer Therapeutics, Institute for Cancer Research, Block E, 15 Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, UK. [email protected]
Pages 911-915 | Published online: 24 Feb 2005

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Karol Sikora. (2004) Diagnostics in cancer drug development. Expert Review of Molecular Diagnostics 4:2, pages 127-129.
Read now

Articles from other publishers (9)

Satsuki Yamada, Jozef Bartunek, Atta Behfar & Andre Terzic. (2021) Mass Customized Outlook for Regenerative Heart Failure Care. International Journal of Molecular Sciences 22:21, pages 11394.
Crossref
Tomás G. Villa & Miguel Viñas. 2016. New Weapons to Control Bacterial Growth. New Weapons to Control Bacterial Growth 1 13 .
Alison H.M. Reid, Richard Baird & Paul Workman. 2008. Principles of Molecular Oncology. Principles of Molecular Oncology 317 365 .
Julia Wulfkuhle, Virginia Espina, Lance Liotta & Emanuel Petricoin. (2004) Genomic and proteomic technologies for individualisation and improvement of cancer treatment. European Journal of Cancer 40:17, pages 2623-2632.
Crossref
Karol Sikora. (2004) Personalized cancer therapy – the key to the future. Pharmacogenomics 5:3, pages 225-228.
Crossref
Richard Baird & Paul Workman. 2004. Principles of Molecular Oncology. Principles of Molecular Oncology 569 606 .
Vyomesh Patel, Chidchanok Leethanakul, Panomwat Amornphimoltham & J. Silvio Gutkind. 2003. Head and Neck Cancer. Head and Neck Cancer 509 VIII .
Karol Sikora. (2002) Surrogate endpoints in cancer drug development. Drug Discovery Today 7:18, pages 951-956.
Crossref
Paul A. Clarke, Robert te Poele, Richard Wooster & Paul Workman. (2001) Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin.. Biochemical Pharmacology 62:10, pages 1311-1336.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.